Department of Surgery, Division of Pediatric Surgery, University of Manitoba, and Children's Hospital Research Institute of Manitoba, AE402-820 Sherbrook Street, Winnipeg, MB, R3A 1S1, Canada.
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Pediatr Surg Int. 2023 Jan 20;39(1):86. doi: 10.1007/s00383-022-05357-y.
To assess real-world educational outcomes, neurodevelopmental disorders and mental health disorders in patients with intestinal atresia (IA) and compare these to outcomes to age-matched controls.
We performed a retrospective case-control study of children with IA born between 1991 and 2017. We evaluated educational outcomes using an Early Developmental Instrument, Grades 3, 7 and 8 assessments, Grade 9 completion and performance, high school graduation, and neurodevelopmental and mental health disorders using International Classification of Diseases codes available from a population-based dataset.
We identified a total of 94 IA cases and 940 date-of-birth-matched controls. Cases with chromosomal anomalies were more likely to fail the Early Developmental Instrument (OR = 2.88, p = 0.037), Grade 8 reading (OR = 2.94, p = 0.043) and Grade 12 (OR = 3.25, p = 0.036); cases without chromosomal anomalies were at no greater risk than their peers of failing to meet expectations and did not have an increased risk of anxiety (OR = 0.48, p = 0.12), depression (OR = 0.74, p = 0.6) or hyperactivity disorder (OR = 1.92, p = 0.087).
Our study demonstrated that IA patients without chromosomal anomalies are not at higher risk of neurodevelopmental and mental health disorders than controls. These results will offer more accurate outcome predictions for parents of children with IA.
评估肠闭锁(IA)患者的真实世界教育结果、神经发育障碍和精神健康障碍,并将其与年龄匹配的对照组进行比较。
我们对 1991 年至 2017 年间出生的 IA 患儿进行了回顾性病例对照研究。我们使用早期发育工具、3 年级、7 年级和 8 年级评估、9 年级完成情况和成绩、高中毕业率,以及基于人群的数据集提供的国际疾病分类编码来评估神经发育和精神健康障碍。
我们共确定了 94 例 IA 病例和 940 名出生日期匹配的对照。染色体异常的病例更有可能无法通过早期发育工具(OR=2.88,p=0.037)、8 年级阅读(OR=2.94,p=0.043)和 12 年级(OR=3.25,p=0.036)评估;无染色体异常的病例与同龄人相比,不符合预期的风险没有增加,且焦虑症(OR=0.48,p=0.12)、抑郁症(OR=0.74,p=0.6)或多动症(OR=1.92,p=0.087)的风险也没有增加。
我们的研究表明,无染色体异常的 IA 患者与对照组相比,神经发育和精神健康障碍的风险并不更高。这些结果将为 IA 患儿的家长提供更准确的预后预测。